Rayno Biopharmaceutical Picks For 2016
- Focus is larger cap stocks that pay dividends with one speculative pick (BLUE).
- XBI is a potential trade for momentum but the IBB can be used for larger cap rebalancing.
- New picks will be added should technicals in the sector hold.
- Large cap update after Q1 earnings reports.
See comments in archives. Note that the XBI can be used for rebalancing and momentum trades. It is very volatile but hit a recent low on 2/11/16 in the $45 range.
| Company | Ticker | Date Started | Price | Price 4/12/16 | % Perf | |
| Abbvie, Inc. | ABBV | 2/3/2016 | 56.49 | 59.89 | 6 | |
| bluebird bio,Inc. | BLUE | 2/3/2016 | 43.75 | 47.66 | 8.9 | |
| Bristol-Myers Squibb | BMY | 2/16/2016 | 61 | 66.84 | 9.6 | |
| Gilead Sciences, Inc. | GILD | 2/3/2016 | 85.8 | 97.24 | 13.3 | |
| Roche ADR | RHBBY | 4/4/2016 | 30.36 | 32 | 5.4 | |
| SPDR S&P ETF | XBI | var trades | 54.99 | |||